L.M.L.M.BrownL.M.L.M., Helicobacter pylori: epidemiology and routes of transmission, „Epidemiologic Reviews”, 22 (2), 2000, s. 283–297, DOI: 10.1093/oxfordjournals.epirev.a018040, PMID: 11218379 [dostęp 2021-03-02].
G.G.BizzozeroG.G., Ueber die schlauchförmigen Drüsen des Magendarmkanals und die Beziehungen ihres Epithels zu dem Oberflächenepithel der Schleimhaut: Zweite Mittheilung, „Archiv für Mikroskopische Anatomie”, 40 (1), 1892, s. 325–375, DOI: 10.1007/BF02954497 [dostęp 2021-03-02](niem.).
H.L.H.L.KornbergH.L.H.L., R.E.R.E.DaviesR.E.R.E., D.R.D.R.WoodD.R.D.R., The activity and function of gastric urease in the cat, „The Biochemical Journal”, 56 (3), 1954, s. 363–372, DOI: 10.1042/bj0560363, PMID: 13140215, PMCID: PMC1269634 [dostęp 2021-03-02].
B.J.B.J.MarshallB.J.B.J. i inni, Attempt to fulfil Koch's postulates for pyloric Campylobacter, „The Medical Journal of Australia”, 142 (8), 1985, s. 436–439, DOI: 10.5694/j.1326-5377.1985.tb113443.x, PMID: 3982345 [dostęp 2021-03-02].
TeresaT.StarzyńskaTeresaT., PeterP.MalfertheinerPeterP., Helicobacter and digestive malignancies, „Helicobacter”, 11 Suppl 1, 2006, s. 32–35, DOI: 10.1111/j.1478-405X.2006.00431.x, PMID: 16925609 [dostęp 2021-03-02].
BodoB.LinzBodoB. i inni, An African origin for the intimate association between humans and Helicobacter pylori, „Nature”, 445 (7130), 2007, s. 915–918, DOI: 10.1038/nature05562, PMID: 17287725, PMCID: PMC1847463 [dostęp 2021-03-02].
StephanieS.Bury-MonéStephanieS. i inni, Is Helicobacter pylori a true microaerophile?, „Helicobacter”, 11 (4), 2006, s. 296–303, DOI: 10.1111/j.1523-5378.2006.00413.x, PMID: 16882333 [dostęp 2021-03-02].
Jonathan W.J.W.OlsonJonathan W.J.W., Robert J.R.J.MaierRobert J.R.J., Molecular hydrogen as an energy source for Helicobacter pylori, „Science”, 298 (5599), 2002, s. 1788–1790, DOI: 10.1126/science.1077123, PMID: 12459589 [dostęp 2021-03-02].
R.M.R.M.StarkR.M.R.M. i inni, Biofilm formation by Helicobacter pylori, „Letters in Applied Microbiology”, 28 (2), 1999, s. 121–126, DOI: 10.1046/j.1365-2672.1999.00481.x, PMID: 10063642 [dostęp 2021-03-02].
W.Y.W.Y.ChanW.Y.W.Y. i inni, Coccoid forms of Helicobacter pylori in the human stomach, „American Journal of Clinical Pathology”, 102 (4), 1994, s. 503–507, DOI: 10.1093/ajcp/102.4.503, PMID: 7524304 [dostęp 2021-03-02].
X.X.JiangX.X., M.P.M.P.DoyleM.P.M.P., Effect of environmental and substrate factors on survival and growth of Helicobacter pylori, „Journal of Food Protection”, 61 (8), 1998, s. 929–933, DOI: 10.4315/0362-028x-61.8.929, PMID: 9713749 [dostęp 2021-03-02].
Johannes G.J.G.KustersJohannes G.J.G., Arnoud H.M. vanA.H.M.VlietArnoud H.M. vanA.H.M., Ernst J.E.J.KuipersErnst J.E.J., Pathogenesis of Helicobacter pylori infection, „Clinical Microbiology Reviews”, 19 (3), 2006, s. 449–490, DOI: 10.1128/CMR.00054-05, PMID: 16847081, PMCID: PMC1539101 [dostęp 2021-03-02].
C.C.JosenhansC.C. i inni, Switching of flagellar motility in Helicobacter pylori by reversible length variation of a short homopolymeric sequence repeat in fliP, a gene encoding a basal body protein, „Infection and Immunity”, 68 (8), 2000, s. 4598–4603, DOI: 10.1128/iai.68.8.4598-4603.2000, PMID: 10899861, PMCID: PMC98385 [dostęp 2021-03-02].
GeG.WangGeG. i inni, Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress, „Infection and Immunity”, 74 (12), 2006, s. 6839–6846, DOI: 10.1128/IAI.00991-06, PMID: 17030577, PMCID: PMC1698064 [dostęp 2021-03-02].
GeG.WangGeG., PraveenP.AlamuriPraveenP., Robert J.R.J.MaierRobert J.R.J., The diverse antioxidant systems of Helicobacter pylori, „Molecular Microbiology”, 61 (4), 2006, s. 847–860, DOI: 10.1111/j.1365-2958.2006.05302.x, PMID: 16879643 [dostęp 2021-03-02].
Z.Z.GeZ.Z., D.E.D.E.TaylorD.E.D.E., Contributions of genome sequencing to understanding the biology of Helicobacter pylori, „Annual Review of Microbiology”, 53, 1999, s. 353–387, DOI: 10.1146/annurev.micro.53.1.353, PMID: 10547695 [dostęp 2021-03-02].
F.F.TombolaF.F. i inni, The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia, „The Journal of Clinical Investigation”, 108 (6), 2001, s. 929–937, DOI: 10.1172/JCI13045, PMID: 11560962, PMCID: PMC200932 [dostęp 2021-03-02].
M.M.GranströmM.M., Y.Y.TindbergY.Y., M.M.BlennowM.M., Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age, „Journal of Clinical Microbiology”, 35 (2), 1997, s. 468–470, DOI: 10.1128/JCM.35.2.468-470.1997, PMID: 9003617, PMCID: PMC229601 [dostęp 2021-03-02].
F.F.MégraudF.F., Transmission of Helicobacter pylori: faecal-oral versus oral-oral route, „Alimentary Pharmacology & Therapeutics”, 9 Suppl 2, 1995, s. 85–91, DOI: 10.1111/j.1365-2036.1995.tb00357.x, PMID: 8547533 [dostęp 2021-03-02].
D.R.D.R.CaveD.R.D.R., Transmission and epidemiology of Helicobacter pylori, „The American Journal of Medicine”, 100 (5A), 1996, 12S–17S; discussion 17S–18S, DOI: 10.1016/s0002-9343(96)80224-5, PMID: 8644777 [dostęp 2021-03-02].
Guy D.G.D.EslickGuy D.G.D., Sexual transmission of Helicobacter pylori via oral-anal intercourse, „International journal of STD & AIDS”, 13 (1), 2002, s. 7–11, DOI: 10.1258/0956462021924541, PMID: 11802923 [dostęp 2021-03-02].
D.T.D.T.SmootD.T.D.T., How does Helicobacter pylori cause mucosal damage? Direct mechanisms, „Gastroenterology”, 113 (6 Suppl), 1997, S31–34; discussion S50, DOI: 10.1016/s0016-5085(97)80008-x, PMID: 9394757 [dostęp 2021-03-02].
Martin J.M.J.BlaserMartin J.M.J., John C.J.C.AthertonJohn C.J.C., Helicobacter pylori persistence: biology and disease, „The Journal of Clinical Investigation”, 113 (3), 2004, s. 321–333, DOI: 10.1172/JCI20925, PMID: 14755326, PMCID: PMC324548 [dostęp 2021-03-02].
Mitchell L.M.L.SchubertMitchell L.M.L., David A.D.A.PeuraDavid A.D.A., Control of gastric acid secretion in health and disease, „Gastroenterology”, 134 (7), 2008, s. 1842–1860, DOI: 10.1053/j.gastro.2008.05.021, PMID: 18474247 [dostęp 2021-03-02].
E. M. el-Omar i inni, Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease, „Gastroenterology”, 109 (3), 1995, s. 681–691, DOI: 10.1016/0016-5085(95)90374-7, PMID: 7657096 [dostęp 2021-03-02].
J.J.CalamJ.J., The somatostatin-gastrin link of Helicobacter pylori infection, „Annals of Medicine”, 27 (5), 1995, s. 569–573, DOI: 10.3109/07853899509002471, PMID: 8541034 [dostęp 2021-03-02].
C.J.C.J.TsaiC.J.C.J., Helicobacter pylori infection and peptic ulcer disease in cirrhosis, „Digestive Diseases and Sciences”, 43 (6), 1998, s. 1219–1225, DOI: 10.1023/a:1018899506271, PMID: 9635611 [dostęp 2021-03-02].
YoshioY.YamaokaYoshioY., MototsuguM.KatoMototsuguM., MasahiroM.AsakaMasahiroM., Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains, „Internal Medicine”, 47 (12), 2008, s. 1077–1083, DOI: 10.2169/internalmedicine.47.0975, PMID: 18552463, PMCID: PMC3732488 [dostęp 2021-03-02].
ChangchengCh.WangChangchengCh., YuhongY.YuanYuhongY., Richard H.R.H.HuntRichard H.R.H., The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis, „The American Journal of Gastroenterology”, 102 (8), 2007, s. 1789–1798, DOI: 10.1111/j.1572-0241.2007.01335.x, PMID: 17521398 [dostęp 2021-03-02].
L.M.L.M.AsenjoL.M.L.M., J.P.J.P.GisbertJ.P.J.P., Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review, „Revista Espanola De Enfermedades Digestivas”, 99 (7), 2007, s. 398–404, DOI: 10.4321/s1130-01082007000700006, PMID: 17973584 [dostęp 2021-03-02](ang. • hiszp.).
Sung-BokS.B.LeeSung-BokS.B., Jae-WookJ.W.YangJae-WookJ.W., Chang-SikCh.S.KimChang-SikCh.S., The association between conjunctival MALT lymphoma and Helicobacter pylori, „The British Journal of Ophthalmology”, 92 (4), 2008, s. 534–536, DOI: 10.1136/bjo.2007.132316, PMID: 18369070 [dostęp 2021-03-02].
D. Boixeda deD.B.MiquelD. Boixeda deD.B. i inni, Effect of Helicobacter pylori eradication therapy in rosacea patients, „Revista Espanola De Enfermedades Digestivas”, 98 (7), 2006, s. 501–509, DOI: 10.4321/s1130-01082006000700003, PMID: 17022699 [dostęp 2021-03-02](ang. • hiszp.).
P.P.MalfertheinerP.P. i inni, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, „Gut”, 56 (6), 2007, s. 772–781, DOI: 10.1136/gut.2006.101634, PMID: 17170018, PMCID: PMC1954853 [dostęp 2021-03-02].
NataliaN.ZumkellerNataliaN. i inni, Helicobacter pylori infection and colorectal cancer risk: a meta-analysis, „Helicobacter”, 11 (2), 2006, s. 75–80, DOI: 10.1111/j.1523-5378.2006.00381.x, PMID: 16579836 [dostęp 2021-03-02].
Ya-ShuangY.S.ZhaoYa-ShuangY.S. i inni, Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer, „International Journal of Colorectal Disease”, 23 (9), 2008, s. 875–882, DOI: 10.1007/s00384-008-0479-z, PMID: 18506454 [dostęp 2021-03-02].
TheodorosT.RokkasTheodorosT. i inni, Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis, „Clinical Gastroenterology and Hepatology”, 5 (12), 2007, s. 1413–1417, DOI: 10.1016/j.cgh.2007.08.010, PMID: 17997357 [dostęp 2021-03-02].
R.V.R.V.LordR.V.R.V. i inni, Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma, „The Australian and New Zealand Journal of Surgery”, 70 (1), 2000, s. 26–33, DOI: 10.1046/j.1440-1622.2000.01737.x, PMID: 10696939 [dostęp 2021-03-02].
M.M.KudoM.M. i inni, CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer, „Journal of Clinical Pathology”, 58 (3), 2005, s. 259–262, DOI: 10.1136/jcp.2004.022251, PMID: 15735156, PMCID: PMC1770586 [dostęp 2021-03-02].
M.F.M.F.VaeziM.F.M.F. i inni, CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus, „The American Journal of Gastroenterology”, 95 (9), 2000, s. 2206–2211, DOI: 10.1111/j.1572-0241.2000.02305.x, PMID: 11007219 [dostęp 2021-03-02].
Shi-YingS.Y.XuanShi-YingS.Y. i inni, Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysis, „World Journal of Gastroenterology”, 14 (2), 2008, s. 307–312, DOI: 10.3748/wjg.14.307, PMID: 18186573, PMCID: PMC2675132 [dostęp 2021-03-04].
Shi-YingS.Y.XuanShi-YingS.Y. i inni, Helicobacter infection in hepatocellular carcinoma tissue, „World Journal of Gastroenterology”, 12 (15), 2006, s. 2335–2340, DOI: 10.3748/wjg.v12.i15.2335, PMID: 16688821, PMCID: PMC4088066 [dostęp 2021-03-04].
NicolaN.LeoneNicolaN. i inni, Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma, „Cancer Detection and Prevention”, 27 (6), 2003, s. 494–497, DOI: 10.1016/j.cdp.2003.07.004, PMID: 14642558 [dostęp 2021-03-04].
M.M.RochaM.M. i inni, Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma, „Gut”, 54 (3), 2005, s. 396–401, DOI: 10.1136/gut.2004.042168, PMID: 15710989, PMCID: PMC1774397 [dostęp 2021-03-04].
Maria P.M.P.DoreMaria P.M.P. i inni, Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma, „Digestive Diseases and Sciences”, 47 (7), 2002, s. 1638–1643, DOI: 10.1023/a:1015848009444, PMID: 12141829 [dostęp 2021-03-04].
Michael G.M.G.BruceMichael G.M.G., Heidi IngridH.I.MaaroosHeidi IngridH.I., Epidemiology of Helicobacter pylori infection, „Helicobacter”, 13 Suppl 1, 2008, s. 1–6, DOI: 10.1111/j.1523-5378.2008.00631.x, PMID: 18783514 [dostęp 2021-03-04].
S.S.TsujiS.S. i inni, Review article: inflammation-related promotion of gastrointestinal carcinogenesis--a perigenetic pathway, „Alimentary Pharmacology & Therapeutics”, 18 Suppl 1, 2003, s. 82–89, DOI: 10.1046/j.1365-2036.18.s1.22.x, PMID: 12925144 [dostęp 2021-03-04].
MasamiM.SuganumaMasamiM. i inni, TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells, „International Journal of Cancer”, 123 (1), 2008, s. 117–122, DOI: 10.1002/ijc.23484, PMID: 18412243 [dostęp 2021-03-04].
R.P.R.P.LoganR.P.R.P. i inni, Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole, „Gut”, 36 (1), 1995, s. 12–16, DOI: 10.1136/gut.36.1.12, PMID: 7890214, PMCID: PMC1382345 [dostęp 2021-03-04].
BillieB.VelapatiñoBillieB. i inni, Validation of string test for diagnosis of Helicobacter pylori infections, „Journal of Clinical Microbiology”, 44 (3), 2006, s. 976–980, DOI: 10.1128/JCM.44.3.976-980.2006, PMID: 16517886, PMCID: PMC1393125 [dostęp 2021-03-04].
AndreasA.LeodolterAndreasA. i inni, Breath and string test: a diagnostic package for the identification of treatment failure and antibiotic resistance of Helicobacter pylori without the necessity of upper gastrointestinal endoscopy, „World Journal of Gastroenterology”, 11 (4), 2005, s. 584–586, DOI: 10.3748/wjg.v11.i4.584, PMID: 15641151, PMCID: PMC4250816 [dostęp 2021-03-04].
Rupert W.L.R.W.L.LeongRupert W.L.R.W.L. i inni, Evaluation of the string test for the detection of Helicobacter pylori, „World Journal of Gastroenterology”, 9 (2), 2003, s. 309–311, DOI: 10.3748/wjg.v9.i2.309, PMID: 12532455, PMCID: PMC4611335 [dostęp 2021-03-04].
Helen M.H.M.WindsorHelen M.H.M., Emmanuel A.E.A.Abioye-KuteyiEmmanuel A.E.A., Barry J.B.J.MarshallBarry J.B.J., Methodology and transport medium for collection of Helicobacter pylori on a string test in remote locations, „Helicobacter”, 10 (6), 2005, s. 630–634, DOI: 10.1111/j.1523-5378.2005.00355.x, PMID: 16302991 [dostęp 2021-03-04].
AngeloA.LocatelliAngeloA. i inni, Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease., „World Journal of Gastroenterology”, 10 (20), 2004, s. 2997–3000, DOI: 10.3748/wjg.v10.i20.2997, PMID: 15378781, PMCID: PMC4576260.
R.L.R.L.RieplR.L.R.L. i inni, Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection, „Zeitschrift Fur Gastroenterologie”, 38 (1), 2000, s. 13–19, DOI: 10.1055/s-2000-15278, PMID: 10689743 [dostęp 2021-03-09].
KengoK.TokunagaKengoK. i inni, Helicobacter pylori 除菌判定における13C-尿素呼気試験の有用性と問題点 徳永 健吾, 渡辺 一宏, 田中 昭文, 菅野 朝, 今瀬 教人, 石田 均, 高橋 信一 [Evaluation of 13C-urea breath test to confirm eradication of Helicobacter pylori], „Nihon Shokakibyo Gakkai Zasshi”, 102 (2), 2005, s. 176–182, DOI: 10.11405/nisshoshi.102.176, PMID: 15747534 [dostęp 2021-03-09](jap.).
V.V.AhujaV.V., C.S.C.S.BalC.S.C.S., M.P.M.P.SharmaM.P.M.P., Can the C-14 urea breath test replace follow-up endoscopic biopsies in patients treated for Helicobacter pylori infection?, „Clinical Nuclear Medicine”, 23 (12), 1998, s. 815–819, DOI: 10.1097/00003072-199812000-00005, PMID: 9858292 [dostęp 2021-03-09].
Chander M.Ch.M.PathakChander M.Ch.M. i inni, Kinetics of 14carbon dioxide excretion from 14C-urea by oral commensal flora, „Journal of Gastroenterology and Hepatology”, 23 (10), 2008, s. 1603–1607, DOI: 10.1111/j.1440-1746.2008.05323.x, PMID: 18444994 [dostęp 2021-03-09].
ShahjahanS.KabirShahjahanS., Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review, „Helicobacter”, 9 (2), 2004, s. 115–123, DOI: 10.1111/j.1083-4389.2004.00207.x, PMID: 15068412 [dostęp 2021-03-09].
C.W.C.W.HowdenC.W.C.W., R.H.R.H.HuntR.H.R.H., Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology, „The American Journal of Gastroenterology”, 93 (12), 1998, s. 2330–2338, DOI: 10.1111/j.1572-0241.1998.00684.x, PMID: 9860388 [dostęp 2021-03-09]. Przedruk w j. polskim: Diagnostyka i leczenie zakażenia Helicobacter pylori [online], Medycyna Praktyczna [dostęp 2021-03-09].
Cindy M.C.M.DierikxCindy M.C.M. i inni, Serum- and animal tissue-free medium for transport and growth of Helicobacter pylori, „FEMS immunology and medical microbiology”, 50 (2), 2007, s. 239–243, DOI: 10.1111/j.1574-695X.2007.00211.x, PMID: 17298584 [dostęp 2021-03-09].
M.G.M.G.MorshedM.G.M.G. i inni, Growth medium containing cyclodextrin and low concentration of horse serum for cultivation of Helicobacter pylori, „Microbiology and Immunology”, 38 (11), 1994, s. 897–900, DOI: 10.1111/j.1348-0421.1994.tb02143.x, PMID: 7898389 [dostęp 2021-03-09].
R.R.OlivieriR.R. i inni, Growth of Helicobacter pylori in media containing cyclodextrins, „Journal of Clinical Microbiology”, 31 (1), 1993, s. 160–162, DOI: 10.1128/JCM.31.1.160-162.1993, PMID: 8417026, PMCID: PMC262644 [dostęp 2021-03-09].
Alba E.A.E.VegaAlba E.A.E. i inni, Growth of Helicobacter pylori in medium supplemented with cyanobacterial extract, „Journal of Clinical Microbiology”, 41 (12), 2003, s. 5384–5388, DOI: 10.1128/jcm.41.12.5384-5388.2003, PMID: 14662915, PMCID: PMC309022 [dostęp 2021-03-09].
MiyukiM.HasegawaMiyukiM. i inni, 新 し く開発 したHelicobacter pylori選 択 分 離 培 地Columbia horse biood agar HPの 有 用性 に関 す る複 数施 設 評 価 [A multicenter study of a new Helicobacter pylori selective medium. Columbia horse blood agar HP], „Kansenshogaku Zasshi”, 76 (5), 2002, s. 341–346, DOI: 10.11150/kansenshogakuzasshi1970.76.341, PMID: 12073569 [dostęp 2021-03-09](jap.).
M.M.ShahamatM.M. i inni, Evaluation of liquid media for growth of Helicobacter pylori, „Journal of Clinical Microbiology”, 29 (12), 1991, s. 2835–2837, DOI: 10.1128/JCM.29.12.2835-2837.1991, PMID: 1757556, PMCID: PMC270442 [dostęp 2021-03-09].
H.X.H.X.XiaH.X.H.X., C.T.C.T.KeaneC.T.C.T., C.A.C.A.O'MorainC.A.C.A., Determination of the optimal transport system for Helicobacter pylori cultures, „Journal of Medical Microbiology”, 39 (5), 1993, s. 334–337, DOI: 10.1099/00222615-39-5-334, PMID: 8246249 [dostęp 2021-03-09].
L.L.LaineL.L. i inni, Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori, „Gastrointestinal Endoscopy”, 45 (6), 1997, s. 463–467, DOI: 10.1016/s0016-5107(97)70174-3, PMID: 9199901 [dostęp 2021-03-09].
J.K.J.K.EshunJ.K.J.K. i inni, Comparison of immunohistochemistry and silver stain for the diagnosis of pediatric Helicobacter pylori infection in urease-negative gastric biopsies, „Pediatric and Developmental Pathology”, 4 (1), 2001, s. 82–88, DOI: 10.1007/s100240010129, PMID: 11200495 [dostęp 2021-03-09].
R.H.R.H.HuntR.H.R.H., C.A.C.A.FalloneC.A.C.A., A.B.A.B.ThomsonA.B.A.B., Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group, „Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie”, 13 (3), 1999, s. 213–217, DOI: 10.1155/1999/180751, PMID: 10331931 [dostęp 2021-03-09].
P.P.MalfertheinerP.P. i inni, Current concepts in the management of Helicobacter pylori infection – the Maastricht 2-2000 Consensus Report, „Alimentary Pharmacology & Therapeutics”, 16 (2), 2002, s. 167–180, DOI: 10.1046/j.1365-2036.2002.01169.x, PMID: 11860399 [dostęp 2021-03-09].
L.L.FischbachL.L., E.L.E.L.EvansE.L.E.L., Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori, „Alimentary Pharmacology & Therapeutics”, 26 (3), 2007, s. 343–357, DOI: 10.1111/j.1365-2036.2007.03386.x, PMID: 17635369 [dostęp 2021-03-09].
Perttu EtP.E.ArkkilaPerttu EtP.E. i inni, Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers, „European Journal of Gastroenterology & Hepatology”, 17 (1), 2005, s. 93–101, DOI: 10.1097/00042737-200501000-00018, PMID: 15647648 [dostęp 2021-03-09].
A.C.A.C.FordA.C.A.C. i inni, Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients, „The Cochrane Database of Systematic Reviews” (2), 2006, art. nr CD003840, DOI: 10.1002/14651858.CD003840.pub5, PMID: 16625592 [dostęp 2021-03-09].
CarlosC.Robles-JaraCarlosC. i inni, Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?, „World Journal of Gastroenterology”, 14 (18), 2008, s. 2838–2843, DOI: 10.3748/wjg.14.2838, PMID: 18473407, PMCID: PMC2710724 [dostęp 2021-03-09].
R.R.VicenteR.R. i inni, Erradicación de Helicobacter pylori en pacientes con úlcera péptica tras fracaso de dos tratamientos previos: estudio prospectivo guiado por cultivo, „Gastroenterologia y Hepatologia”, 25 (7), 2002, s. 438–442, DOI: 10.1016/s0210-5705(02)70283-5, PMID: 12139836 [dostęp 2021-03-09](hiszp.).
David Y.D.Y.GrahamDavid Y.D.Y., AkikoA.ShiotaniAkikoA., New concepts of resistance in the treatment of Helicobacter pylori infections, „Nature Clinical Practice. Gastroenterology & Hepatology”, 5 (6), 2008, s. 321–331, DOI: 10.1038/ncpgasthep1138, PMID: 18446147, PMCID: PMC2841357 [dostęp 2021-03-09].
DinoD.VairaDinoD. i inni, Terapia dell'infezione da Helicobacter pylori. Attuali criteri, „Recenti Progressi in Medicina”, 98 (11), 2007, s. 574–582, DOI: 10.1701/303.3583, PMID: 18044409 [dostęp 2021-03-09](wł.).
BarryB.MarshallBarryB., Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients, „Annals of Internal Medicine”, 148 (12), 2008, s. 962–963, DOI: 10.7326/0003-4819-148-12-200806170-00227, PMID: 18490666 [dostęp 2021-03-09].
F.F.PernaF.F. i inni, Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance, „Digestive and Liver Disease”, 39 (11), 2007, s. 1001–1005, DOI: 10.1016/j.dld.2007.06.016, PMID: 17889627 [dostęp 2021-03-09].
P.I.P.I.HsuP.I.P.I. i inni, Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures, „European Journal of Clinical Investigation”, 38 (6), 2008, s. 404–409, DOI: 10.1111/j.1365-2362.2008.01951.x, PMID: 18435764 [dostęp 2021-03-09].
IntetsuI.KobayashiIntetsuI. i inni, Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005, „Journal of Clinical Microbiology”, 45 (12), 2007, s. 4006–4010, DOI: 10.1128/JCM.00740-07, PMID: 17942652, PMCID: PMC2168569 [dostęp 2021-03-09].
Mark V.M.V.GalanMark V.M.V., Arfana A.A.A.KishanArfana A.A.A., Ann L.A.L.SilvermanAnn L.A.L., Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report, „Digestive Diseases and Sciences”, 49 (7-8), 2004, s. 1088–1090, DOI: 10.1023/b:ddas.0000037792.04787.8a, PMID: 15387326 [dostęp 2021-03-09].
SotiriosS.ParaschosSotiriosS. i inni, In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori, „Antimicrobial Agents and Chemotherapy”, 51 (2), 2007, s. 551–559, DOI: 10.1128/AAC.00642-06, PMID: 17116667, PMCID: PMC1797732 [dostęp 2021-03-09].
James R.J.R.BebbJames R.J.R. i inni, Mastic gum has no effect on Helicobacter pylori load in vivo, „The Journal of Antimicrobial Chemotherapy”, 52 (3), 2003, s. 522–523, DOI: 10.1093/jac/dkg366, PMID: 12888582 [dostęp 2021-03-09].
Michael F.M.F.LoughlinMichael F.M.F., Dlawer A.D.A.Ala'AldeenDlawer A.D.A., Peter J.P.J.JenksPeter J.P.J., Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice, „The Journal of Antimicrobial Chemotherapy”, 51 (2), 2003, s. 367–371, DOI: 10.1093/jac/dkg057, PMID: 12562704 [dostęp 2021-03-09].
J.F.J.F.TombJ.F.J.F. i inni, The complete genome sequence of the gastric pathogen Helicobacter pylori, „Nature”, 388 (6642), 1997, s. 539–547, DOI: 10.1038/41483, PMID: 9252185 [dostęp 2021-03-09].
David N.D.N.BaldwinDavid N.D.N. i inni, Identification of Helicobacter pylori genes that contribute to stomach colonization, „Infection and Immunity”, 75 (2), 2007, s. 1005–1016, DOI: 10.1128/IAI.01176-06, PMID: 17101654, PMCID: PMC1828534 [dostęp 2021-03-09].
C.W.C.W.HowdenC.W.C.W., R.H.R.H.HuntR.H.R.H., Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology, „The American Journal of Gastroenterology”, 93 (12), 1998, s. 2330–2338, DOI: 10.1111/j.1572-0241.1998.00684.x, PMID: 9860388 [dostęp 2021-03-09]. Przedruk w j. polskim: Diagnostyka i leczenie zakażenia Helicobacter pylori [online], Medycyna Praktyczna [dostęp 2021-03-09].
L.M.L.M.BrownL.M.L.M., Helicobacter pylori: epidemiology and routes of transmission, „Epidemiologic Reviews”, 22 (2), 2000, s. 283–297, DOI: 10.1093/oxfordjournals.epirev.a018040, PMID: 11218379 [dostęp 2021-03-02].
H.L.H.L.KornbergH.L.H.L., R.E.R.E.DaviesR.E.R.E., D.R.D.R.WoodD.R.D.R., The activity and function of gastric urease in the cat, „The Biochemical Journal”, 56 (3), 1954, s. 363–372, DOI: 10.1042/bj0560363, PMID: 13140215, PMCID: PMC1269634 [dostęp 2021-03-02].
A.A.MorrisA.A., G.G.NicholsonG.G., Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH, „The American Journal of Gastroenterology”, 82 (3), 1987, s. 192–199, PMID: 3826027 [dostęp 2021-03-02].
B.J.B.J.MarshallB.J.B.J. i inni, Attempt to fulfil Koch's postulates for pyloric Campylobacter, „The Medical Journal of Australia”, 142 (8), 1985, s. 436–439, DOI: 10.5694/j.1326-5377.1985.tb113443.x, PMID: 3982345 [dostęp 2021-03-02].
E. OcañaE.O.AndradeE. OcañaE.O. i inni, [Campylobacter pylori in endoscopic biopsies of the gastric antrum and its association with chronic gastritis], „Revista De Gastroenterologia De Mexico”, 54 (4), 1989, s. 207–211, PMID: 2616983 [dostęp 2021-03-02](hiszp.).
TeresaT.StarzyńskaTeresaT., PeterP.MalfertheinerPeterP., Helicobacter and digestive malignancies, „Helicobacter”, 11 Suppl 1, 2006, s. 32–35, DOI: 10.1111/j.1478-405X.2006.00431.x, PMID: 16925609 [dostęp 2021-03-02].
BodoB.LinzBodoB. i inni, An African origin for the intimate association between humans and Helicobacter pylori, „Nature”, 445 (7130), 2007, s. 915–918, DOI: 10.1038/nature05562, PMID: 17287725, PMCID: PMC1847463 [dostęp 2021-03-02].
StephanieS.Bury-MonéStephanieS. i inni, Is Helicobacter pylori a true microaerophile?, „Helicobacter”, 11 (4), 2006, s. 296–303, DOI: 10.1111/j.1523-5378.2006.00413.x, PMID: 16882333 [dostęp 2021-03-02].
Jonathan W.J.W.OlsonJonathan W.J.W., Robert J.R.J.MaierRobert J.R.J., Molecular hydrogen as an energy source for Helicobacter pylori, „Science”, 298 (5599), 2002, s. 1788–1790, DOI: 10.1126/science.1077123, PMID: 12459589 [dostęp 2021-03-02].
R.M.R.M.StarkR.M.R.M. i inni, Biofilm formation by Helicobacter pylori, „Letters in Applied Microbiology”, 28 (2), 1999, s. 121–126, DOI: 10.1046/j.1365-2672.1999.00481.x, PMID: 10063642 [dostęp 2021-03-02].
W.Y.W.Y.ChanW.Y.W.Y. i inni, Coccoid forms of Helicobacter pylori in the human stomach, „American Journal of Clinical Pathology”, 102 (4), 1994, s. 503–507, DOI: 10.1093/ajcp/102.4.503, PMID: 7524304 [dostęp 2021-03-02].
X.X.JiangX.X., M.P.M.P.DoyleM.P.M.P., Effect of environmental and substrate factors on survival and growth of Helicobacter pylori, „Journal of Food Protection”, 61 (8), 1998, s. 929–933, DOI: 10.4315/0362-028x-61.8.929, PMID: 9713749 [dostęp 2021-03-02].
Johannes G.J.G.KustersJohannes G.J.G., Arnoud H.M. vanA.H.M.VlietArnoud H.M. vanA.H.M., Ernst J.E.J.KuipersErnst J.E.J., Pathogenesis of Helicobacter pylori infection, „Clinical Microbiology Reviews”, 19 (3), 2006, s. 449–490, DOI: 10.1128/CMR.00054-05, PMID: 16847081, PMCID: PMC1539101 [dostęp 2021-03-02].
C.C.JosenhansC.C. i inni, Switching of flagellar motility in Helicobacter pylori by reversible length variation of a short homopolymeric sequence repeat in fliP, a gene encoding a basal body protein, „Infection and Immunity”, 68 (8), 2000, s. 4598–4603, DOI: 10.1128/iai.68.8.4598-4603.2000, PMID: 10899861, PMCID: PMC98385 [dostęp 2021-03-02].
GeG.WangGeG. i inni, Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress, „Infection and Immunity”, 74 (12), 2006, s. 6839–6846, DOI: 10.1128/IAI.00991-06, PMID: 17030577, PMCID: PMC1698064 [dostęp 2021-03-02].
GeG.WangGeG., PraveenP.AlamuriPraveenP., Robert J.R.J.MaierRobert J.R.J., The diverse antioxidant systems of Helicobacter pylori, „Molecular Microbiology”, 61 (4), 2006, s. 847–860, DOI: 10.1111/j.1365-2958.2006.05302.x, PMID: 16879643 [dostęp 2021-03-02].
Z.Z.GeZ.Z., D.E.D.E.TaylorD.E.D.E., Contributions of genome sequencing to understanding the biology of Helicobacter pylori, „Annual Review of Microbiology”, 53, 1999, s. 353–387, DOI: 10.1146/annurev.micro.53.1.353, PMID: 10547695 [dostęp 2021-03-02].
F.F.TombolaF.F. i inni, The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia, „The Journal of Clinical Investigation”, 108 (6), 2001, s. 929–937, DOI: 10.1172/JCI13045, PMID: 11560962, PMCID: PMC200932 [dostęp 2021-03-02].
M.M.GranströmM.M., Y.Y.TindbergY.Y., M.M.BlennowM.M., Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age, „Journal of Clinical Microbiology”, 35 (2), 1997, s. 468–470, DOI: 10.1128/JCM.35.2.468-470.1997, PMID: 9003617, PMCID: PMC229601 [dostęp 2021-03-02].
P.D.P.D.KleinP.D.P.D. i inni, The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age, „The American Journal of Gastroenterology”, 89 (12), 1994, s. 2196–2200, PMID: 7977241 [dostęp 2021-03-02].
F.F.MégraudF.F., Transmission of Helicobacter pylori: faecal-oral versus oral-oral route, „Alimentary Pharmacology & Therapeutics”, 9 Suppl 2, 1995, s. 85–91, DOI: 10.1111/j.1365-2036.1995.tb00357.x, PMID: 8547533 [dostęp 2021-03-02].
D.R.D.R.CaveD.R.D.R., Transmission and epidemiology of Helicobacter pylori, „The American Journal of Medicine”, 100 (5A), 1996, 12S–17S; discussion 17S–18S, DOI: 10.1016/s0002-9343(96)80224-5, PMID: 8644777 [dostęp 2021-03-02].
Guy D.G.D.EslickGuy D.G.D., Sexual transmission of Helicobacter pylori via oral-anal intercourse, „International journal of STD & AIDS”, 13 (1), 2002, s. 7–11, DOI: 10.1258/0956462021924541, PMID: 11802923 [dostęp 2021-03-02].
D.T.D.T.SmootD.T.D.T., How does Helicobacter pylori cause mucosal damage? Direct mechanisms, „Gastroenterology”, 113 (6 Suppl), 1997, S31–34; discussion S50, DOI: 10.1016/s0016-5085(97)80008-x, PMID: 9394757 [dostęp 2021-03-02].
Martin J.M.J.BlaserMartin J.M.J., John C.J.C.AthertonJohn C.J.C., Helicobacter pylori persistence: biology and disease, „The Journal of Clinical Investigation”, 113 (3), 2004, s. 321–333, DOI: 10.1172/JCI20925, PMID: 14755326, PMCID: PMC324548 [dostęp 2021-03-02].
Mitchell L.M.L.SchubertMitchell L.M.L., David A.D.A.PeuraDavid A.D.A., Control of gastric acid secretion in health and disease, „Gastroenterology”, 134 (7), 2008, s. 1842–1860, DOI: 10.1053/j.gastro.2008.05.021, PMID: 18474247 [dostęp 2021-03-02].
E. M. el-Omar i inni, Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease, „Gastroenterology”, 109 (3), 1995, s. 681–691, DOI: 10.1016/0016-5085(95)90374-7, PMID: 7657096 [dostęp 2021-03-02].
W.L.W.L.PetersonW.L.W.L. i inni, Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori, „The American Journal of Gastroenterology”, 88 (12), 1993, s. 2038–2043, PMID: 8249971 [dostęp 2021-03-02].
J.J.CalamJ.J., The somatostatin-gastrin link of Helicobacter pylori infection, „Annals of Medicine”, 27 (5), 1995, s. 569–573, DOI: 10.3109/07853899509002471, PMID: 8541034 [dostęp 2021-03-02].
C.J.C.J.TsaiC.J.C.J., Helicobacter pylori infection and peptic ulcer disease in cirrhosis, „Digestive Diseases and Sciences”, 43 (6), 1998, s. 1219–1225, DOI: 10.1023/a:1018899506271, PMID: 9635611 [dostęp 2021-03-02].
YoshioY.YamaokaYoshioY., MototsuguM.KatoMototsuguM., MasahiroM.AsakaMasahiroM., Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains, „Internal Medicine”, 47 (12), 2008, s. 1077–1083, DOI: 10.2169/internalmedicine.47.0975, PMID: 18552463, PMCID: PMC3732488 [dostęp 2021-03-02].
ChangchengCh.WangChangchengCh., YuhongY.YuanYuhongY., Richard H.R.H.HuntRichard H.R.H., The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis, „The American Journal of Gastroenterology”, 102 (8), 2007, s. 1789–1798, DOI: 10.1111/j.1572-0241.2007.01335.x, PMID: 17521398 [dostęp 2021-03-02].
L.M.L.M.AsenjoL.M.L.M., J.P.J.P.GisbertJ.P.J.P., Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review, „Revista Espanola De Enfermedades Digestivas”, 99 (7), 2007, s. 398–404, DOI: 10.4321/s1130-01082007000700006, PMID: 17973584 [dostęp 2021-03-02](ang. • hiszp.).
Sung-BokS.B.LeeSung-BokS.B., Jae-WookJ.W.YangJae-WookJ.W., Chang-SikCh.S.KimChang-SikCh.S., The association between conjunctival MALT lymphoma and Helicobacter pylori, „The British Journal of Ophthalmology”, 92 (4), 2008, s. 534–536, DOI: 10.1136/bjo.2007.132316, PMID: 18369070 [dostęp 2021-03-02].
D. Boixeda deD.B.MiquelD. Boixeda deD.B. i inni, Effect of Helicobacter pylori eradication therapy in rosacea patients, „Revista Espanola De Enfermedades Digestivas”, 98 (7), 2006, s. 501–509, DOI: 10.4321/s1130-01082006000700003, PMID: 17022699 [dostęp 2021-03-02](ang. • hiszp.).
P.P.MalfertheinerP.P. i inni, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, „Gut”, 56 (6), 2007, s. 772–781, DOI: 10.1136/gut.2006.101634, PMID: 17170018, PMCID: PMC1954853 [dostęp 2021-03-02].
Cristina CijevschiC.C.PrelipceanCristina CijevschiC.C. i inni, Extragastric manifestations of Helicobacter pylori infection, „Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi”, 111 (3), 2007, s. 575–583, PMID: 18293684 [dostęp 2021-03-02].
NataliaN.ZumkellerNataliaN. i inni, Helicobacter pylori infection and colorectal cancer risk: a meta-analysis, „Helicobacter”, 11 (2), 2006, s. 75–80, DOI: 10.1111/j.1523-5378.2006.00381.x, PMID: 16579836 [dostęp 2021-03-02].
Ya-ShuangY.S.ZhaoYa-ShuangY.S. i inni, Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer, „International Journal of Colorectal Disease”, 23 (9), 2008, s. 875–882, DOI: 10.1007/s00384-008-0479-z, PMID: 18506454 [dostęp 2021-03-02].
TheodorosT.RokkasTheodorosT. i inni, Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis, „Clinical Gastroenterology and Hepatology”, 5 (12), 2007, s. 1413–1417, DOI: 10.1016/j.cgh.2007.08.010, PMID: 17997357 [dostęp 2021-03-02].
R.V.R.V.LordR.V.R.V. i inni, Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma, „The Australian and New Zealand Journal of Surgery”, 70 (1), 2000, s. 26–33, DOI: 10.1046/j.1440-1622.2000.01737.x, PMID: 10696939 [dostęp 2021-03-02].
M.M.KudoM.M. i inni, CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer, „Journal of Clinical Pathology”, 58 (3), 2005, s. 259–262, DOI: 10.1136/jcp.2004.022251, PMID: 15735156, PMCID: PMC1770586 [dostęp 2021-03-02].
M.F.M.F.VaeziM.F.M.F. i inni, CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus, „The American Journal of Gastroenterology”, 95 (9), 2000, s. 2206–2211, DOI: 10.1111/j.1572-0241.2000.02305.x, PMID: 11007219 [dostęp 2021-03-02].
Shi-YingS.Y.XuanShi-YingS.Y. i inni, Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysis, „World Journal of Gastroenterology”, 14 (2), 2008, s. 307–312, DOI: 10.3748/wjg.14.307, PMID: 18186573, PMCID: PMC2675132 [dostęp 2021-03-04].
Shi-YingS.Y.XuanShi-YingS.Y. i inni, Helicobacter infection in hepatocellular carcinoma tissue, „World Journal of Gastroenterology”, 12 (15), 2006, s. 2335–2340, DOI: 10.3748/wjg.v12.i15.2335, PMID: 16688821, PMCID: PMC4088066 [dostęp 2021-03-04].
NicolaN.LeoneNicolaN. i inni, Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma, „Cancer Detection and Prevention”, 27 (6), 2003, s. 494–497, DOI: 10.1016/j.cdp.2003.07.004, PMID: 14642558 [dostęp 2021-03-04].
M.M.RochaM.M. i inni, Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma, „Gut”, 54 (3), 2005, s. 396–401, DOI: 10.1136/gut.2004.042168, PMID: 15710989, PMCID: PMC1774397 [dostęp 2021-03-04].
Maria P.M.P.DoreMaria P.M.P. i inni, Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma, „Digestive Diseases and Sciences”, 47 (7), 2002, s. 1638–1643, DOI: 10.1023/a:1015848009444, PMID: 12141829 [dostęp 2021-03-04].
NicolaN.CoppolaNicolaN. i inni, Helicobacter spp. and liver diseases, „Le Infezioni in Medicina”, 11 (4), 2003, s. 201–207, PMID: 14988668 [dostęp 2021-03-04](ang.).
Mohammed S.M.S.Al-MarhoonMohammed S.M.S., Is there a role for Helicobacter pylori infection in urological diseases?, „Urology Journal”, 5 (3), 2008, s. 139–143, PMID: 18825618 [dostęp 2021-03-04].
Michael G.M.G.BruceMichael G.M.G., Heidi IngridH.I.MaaroosHeidi IngridH.I., Epidemiology of Helicobacter pylori infection, „Helicobacter”, 13 Suppl 1, 2008, s. 1–6, DOI: 10.1111/j.1523-5378.2008.00631.x, PMID: 18783514 [dostęp 2021-03-04].
S.S.TsujiS.S. i inni, Review article: inflammation-related promotion of gastrointestinal carcinogenesis--a perigenetic pathway, „Alimentary Pharmacology & Therapeutics”, 18 Suppl 1, 2003, s. 82–89, DOI: 10.1046/j.1365-2036.18.s1.22.x, PMID: 12925144 [dostęp 2021-03-04].
MasamiM.SuganumaMasamiM. i inni, TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells, „International Journal of Cancer”, 123 (1), 2008, s. 117–122, DOI: 10.1002/ijc.23484, PMID: 18412243 [dostęp 2021-03-04].
R.P.R.P.LoganR.P.R.P. i inni, Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole, „Gut”, 36 (1), 1995, s. 12–16, DOI: 10.1136/gut.36.1.12, PMID: 7890214, PMCID: PMC1382345 [dostęp 2021-03-04].
G.G.JarczykG.G. i inni, [Urease test, microbiologic tests, histologic and serologic tests for the evaluation of Helicobacter pylori infections in persons with peptic ulcer and gastritis], „Polski Tygodnik Lekarski”, 51 (14-18), 1996, s. 219–222, PMID: 8966163 [dostęp 2021-03-04](pol.).
OscarO.Aguilar-SotoOscarO. i inni, [Comparative study between rapid urease test, imprint and histopathological study for Helicobacter pylori diagnosis], „Revista De Gastroenterologia De Mexico”, 69 (3), 2004, s. 136–142, PMID: 15759784 [dostęp 2021-03-04](hiszp.).
L.L.TrevisaniL.L. i inni, Usefulness of brushing urease test for diagnosis of Helicobacter pylori infection, „Italian Journal of Gastroenterology and Hepatology”, 30 (6), 1998, s. 599–601, PMID: 10076780 [dostęp 2021-03-04].
N.N.LeeN.N., H.N.H.N.TsaiH.N.H.N., K.M.K.M.FangK.M.K.M., Comparison of four different methods for detection of Helicobacter pylori from gastric biopsies, „Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi = Chinese Journal of Microbiology and Immunology”, 23 (3), 1990, s. 220–231, PMID: 2091902 [dostęp 2021-03-04].
M.M.SongM.M., [Detection of Helicobacter pylori in human saliva by using nested polymerase chain reaction], „Zhonghua Liu Xing Bing Xue Za Zhi”, 14 (4), 1993, s. 237–240, PMID: 8143325 [dostęp 2021-03-04](chiń.).
E.E.Pérez-TralleroE.E., M.M.MontesM.M., String test for Helicobacter pylori, „Journal of Clinical Microbiology”, 38 (11), 2000, s. 4303, PMID: 11185067, PMCID: PMC87595 [dostęp 2021-03-09].
BillieB.VelapatiñoBillieB. i inni, Validation of string test for diagnosis of Helicobacter pylori infections, „Journal of Clinical Microbiology”, 44 (3), 2006, s. 976–980, DOI: 10.1128/JCM.44.3.976-980.2006, PMID: 16517886, PMCID: PMC1393125 [dostęp 2021-03-04].
AndreasA.LeodolterAndreasA. i inni, Breath and string test: a diagnostic package for the identification of treatment failure and antibiotic resistance of Helicobacter pylori without the necessity of upper gastrointestinal endoscopy, „World Journal of Gastroenterology”, 11 (4), 2005, s. 584–586, DOI: 10.3748/wjg.v11.i4.584, PMID: 15641151, PMCID: PMC4250816 [dostęp 2021-03-04].
Rupert W.L.R.W.L.LeongRupert W.L.R.W.L. i inni, Evaluation of the string test for the detection of Helicobacter pylori, „World Journal of Gastroenterology”, 9 (2), 2003, s. 309–311, DOI: 10.3748/wjg.v9.i2.309, PMID: 12532455, PMCID: PMC4611335 [dostęp 2021-03-04].
Helen M.H.M.WindsorHelen M.H.M., Emmanuel A.E.A.Abioye-KuteyiEmmanuel A.E.A., Barry J.B.J.MarshallBarry J.B.J., Methodology and transport medium for collection of Helicobacter pylori on a string test in remote locations, „Helicobacter”, 10 (6), 2005, s. 630–634, DOI: 10.1111/j.1523-5378.2005.00355.x, PMID: 16302991 [dostęp 2021-03-04].
AngeloA.LocatelliAngeloA. i inni, Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease., „World Journal of Gastroenterology”, 10 (20), 2004, s. 2997–3000, DOI: 10.3748/wjg.v10.i20.2997, PMID: 15378781, PMCID: PMC4576260.
MariaM.KorzonekMariaM., Wartość diagnostyczna różnych metod stosowanych w wykrywaniu zakażenia Helicobacter pylori w błonie śluzowej żołądka, „Annales Academiae Medicae Stetinensis”, 43, 1997, s. 143–159, PMID: 9471913 [dostęp 2021-03-09].
MiroslavaM.KaticicMiroslavaM., [Is the only good Helicobacter a dead Helicobacter?], „Medicinski arhiv”, 56 (1 Suppl 1), 2002, s. 17–20, PMID: 12055716.
R.L.R.L.RieplR.L.R.L. i inni, Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection, „Zeitschrift Fur Gastroenterologie”, 38 (1), 2000, s. 13–19, DOI: 10.1055/s-2000-15278, PMID: 10689743 [dostęp 2021-03-09].
KengoK.TokunagaKengoK. i inni, Helicobacter pylori 除菌判定における13C-尿素呼気試験の有用性と問題点 徳永 健吾, 渡辺 一宏, 田中 昭文, 菅野 朝, 今瀬 教人, 石田 均, 高橋 信一 [Evaluation of 13C-urea breath test to confirm eradication of Helicobacter pylori], „Nihon Shokakibyo Gakkai Zasshi”, 102 (2), 2005, s. 176–182, DOI: 10.11405/nisshoshi.102.176, PMID: 15747534 [dostęp 2021-03-09](jap.).
V.V.AhujaV.V., C.S.C.S.BalC.S.C.S., M.P.M.P.SharmaM.P.M.P., Can the C-14 urea breath test replace follow-up endoscopic biopsies in patients treated for Helicobacter pylori infection?, „Clinical Nuclear Medicine”, 23 (12), 1998, s. 815–819, DOI: 10.1097/00003072-199812000-00005, PMID: 9858292 [dostęp 2021-03-09].
V.V.TewariV.V. i inni, 14C-urea breath test for assessment of gastric Helicobacter pylori colonization and eradication, „Indian Journal of Gastroenterology”, 20 (4), 2001, s. 140–143, PMID: 11497171 [dostęp 2021-03-09].
Chander M.Ch.M.PathakChander M.Ch.M. i inni, Kinetics of 14carbon dioxide excretion from 14C-urea by oral commensal flora, „Journal of Gastroenterology and Hepatology”, 23 (10), 2008, s. 1603–1607, DOI: 10.1111/j.1440-1746.2008.05323.x, PMID: 18444994 [dostęp 2021-03-09].
C.M.C.M.PathakC.M.C.M. i inni, Evaluation of 14C-urinary excretion and its comparison with 14CO2 in breath after 14C-urea administration in Helicobacter pylori infection, „The American Journal of Gastroenterology”, 89 (5), 1994, s. 734–738, PMID: 8172148 [dostęp 2021-03-09].
R.R.Moulton-BarrettR.R. i inni, Serum 13C-bicarbonate in the assessment of gastric Helicobacter pylori urease activity, „The American Journal of Gastroenterology”, 88 (3), 1993, s. 369–374, PMID: 7679876 [dostęp 2021-03-09].
L.L.TrevisaniL.L. i inni, Usefulness of brushing urease test for diagnosis of Helicobacter pylori infection, „Italian Journal of Gastroenterology and Hepatology”, 30 (6), 1998, s. 599–601, PMID: 10076780 [dostęp 2021-03-09].
ShahjahanS.KabirShahjahanS., Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review, „Helicobacter”, 9 (2), 2004, s. 115–123, DOI: 10.1111/j.1083-4389.2004.00207.x, PMID: 15068412 [dostęp 2021-03-09].
C.W.C.W.HowdenC.W.C.W., R.H.R.H.HuntR.H.R.H., Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology, „The American Journal of Gastroenterology”, 93 (12), 1998, s. 2330–2338, DOI: 10.1111/j.1572-0241.1998.00684.x, PMID: 9860388 [dostęp 2021-03-09]. Przedruk w j. polskim: Diagnostyka i leczenie zakażenia Helicobacter pylori [online], Medycyna Praktyczna [dostęp 2021-03-09].
Cindy M.C.M.DierikxCindy M.C.M. i inni, Serum- and animal tissue-free medium for transport and growth of Helicobacter pylori, „FEMS immunology and medical microbiology”, 50 (2), 2007, s. 239–243, DOI: 10.1111/j.1574-695X.2007.00211.x, PMID: 17298584 [dostęp 2021-03-09].
M.G.M.G.MorshedM.G.M.G. i inni, Growth medium containing cyclodextrin and low concentration of horse serum for cultivation of Helicobacter pylori, „Microbiology and Immunology”, 38 (11), 1994, s. 897–900, DOI: 10.1111/j.1348-0421.1994.tb02143.x, PMID: 7898389 [dostęp 2021-03-09].
R.R.OlivieriR.R. i inni, Growth of Helicobacter pylori in media containing cyclodextrins, „Journal of Clinical Microbiology”, 31 (1), 1993, s. 160–162, DOI: 10.1128/JCM.31.1.160-162.1993, PMID: 8417026, PMCID: PMC262644 [dostęp 2021-03-09].
Alba E.A.E.VegaAlba E.A.E. i inni, Growth of Helicobacter pylori in medium supplemented with cyanobacterial extract, „Journal of Clinical Microbiology”, 41 (12), 2003, s. 5384–5388, DOI: 10.1128/jcm.41.12.5384-5388.2003, PMID: 14662915, PMCID: PMC309022 [dostęp 2021-03-09].
C.K.C.K.YangC.K.C.K. i inni, [Modified selective medium for isolation of Helicobacter pylori], „Chinese Journal of Microbiology and Immunology”, 25 (2), 1992, s. 108–114, PMID: 1473370 [dostęp 2021-03-09](chiń.).
MiyukiM.HasegawaMiyukiM. i inni, 新 し く開発 したHelicobacter pylori選 択 分 離 培 地Columbia horse biood agar HPの 有 用性 に関 す る複 数施 設 評 価 [A multicenter study of a new Helicobacter pylori selective medium. Columbia horse blood agar HP], „Kansenshogaku Zasshi”, 76 (5), 2002, s. 341–346, DOI: 10.11150/kansenshogakuzasshi1970.76.341, PMID: 12073569 [dostęp 2021-03-09](jap.).
M.M.ShahamatM.M. i inni, Evaluation of liquid media for growth of Helicobacter pylori, „Journal of Clinical Microbiology”, 29 (12), 1991, s. 2835–2837, DOI: 10.1128/JCM.29.12.2835-2837.1991, PMID: 1757556, PMCID: PMC270442 [dostęp 2021-03-09].
H.X.H.X.XiaH.X.H.X., C.T.C.T.KeaneC.T.C.T., C.A.C.A.O'MorainC.A.C.A., Determination of the optimal transport system for Helicobacter pylori cultures, „Journal of Medical Microbiology”, 39 (5), 1993, s. 334–337, DOI: 10.1099/00222615-39-5-334, PMID: 8246249 [dostęp 2021-03-09].
EugeniaE.GospodarekEugeniaE., E.E.SieradzkaE.E., WojciechW.ZegarskiWojciechW., Wykorzystanie 4 metod mikrobiologicznych w wykrywaniu Helicobacter pylori, „Medycyna Doswiadczalna i Mikrobiologia”, 46 (4), 1994, s. 293–300, PMID: 7603130 [dostęp 2021-03-09].
B.E.B.E.KoltsB.E.B.E. i inni, Helicobacter pylori detection: a quality and cost analysis, „The American Journal of Gastroenterology”, 88 (5), 1993, s. 650–655, PMID: 7683175 [dostęp 2021-03-09].
L.L.LaineL.L. i inni, Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori, „Gastrointestinal Endoscopy”, 45 (6), 1997, s. 463–467, DOI: 10.1016/s0016-5107(97)70174-3, PMID: 9199901 [dostęp 2021-03-09].
H.M.H.M.El-ZimaityH.M.H.M. i inni, Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains, „Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc”, 11 (3), 1998, s. 288–291, PMID: 9521477 [dostęp 2021-03-09].
DiclehanD.OrhanDiclehanD. i inni, Immunohistochemical detection of Helicobacter pylori infection in gastric biopsies of urea breath test-positive and -negative pediatric patients, „The Turkish Journal of Pediatrics”, 50 (1), 2008, s. 34–39, PMID: 18365589 [dostęp 2021-03-09].
J.K.J.K.EshunJ.K.J.K. i inni, Comparison of immunohistochemistry and silver stain for the diagnosis of pediatric Helicobacter pylori infection in urease-negative gastric biopsies, „Pediatric and Developmental Pathology”, 4 (1), 2001, s. 82–88, DOI: 10.1007/s100240010129, PMID: 11200495 [dostęp 2021-03-09].
A.M.A.M.HirschlA.M.A.M. i inni, [Campylobacter pylori, gastritis and peptic ulcer], „Wiener Klinische Wochenschrift”, 99 (14), 1987, s. 493–497, PMID: 3630180 [dostęp 2021-03-09](niem.).
R.H.R.H.HuntR.H.R.H., C.A.C.A.FalloneC.A.C.A., A.B.A.B.ThomsonA.B.A.B., Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group, „Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie”, 13 (3), 1999, s. 213–217, DOI: 10.1155/1999/180751, PMID: 10331931 [dostęp 2021-03-09].
P.P.MalfertheinerP.P. i inni, Current concepts in the management of Helicobacter pylori infection – the Maastricht 2-2000 Consensus Report, „Alimentary Pharmacology & Therapeutics”, 16 (2), 2002, s. 167–180, DOI: 10.1046/j.1365-2036.2002.01169.x, PMID: 11860399 [dostęp 2021-03-09].
L.L.FischbachL.L., E.L.E.L.EvansE.L.E.L., Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori, „Alimentary Pharmacology & Therapeutics”, 26 (3), 2007, s. 343–357, DOI: 10.1111/j.1365-2036.2007.03386.x, PMID: 17635369 [dostęp 2021-03-09].
H.J.H.J.O'ConnorH.J.H.J., Eradication of Helicobacter pylori, „European Journal of Gastroenterology & Hepatology”, 6 Suppl 1, 1994, S113–S119, PMID: 7735927 [dostęp 2021-03-09].
Perttu EtP.E.ArkkilaPerttu EtP.E. i inni, Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers, „European Journal of Gastroenterology & Hepatology”, 17 (1), 2005, s. 93–101, DOI: 10.1097/00042737-200501000-00018, PMID: 15647648 [dostęp 2021-03-09].
A.C.A.C.FordA.C.A.C. i inni, Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients, „The Cochrane Database of Systematic Reviews” (2), 2006, art. nr CD003840, DOI: 10.1002/14651858.CD003840.pub5, PMID: 16625592 [dostęp 2021-03-09].
CarlosC.Robles-JaraCarlosC. i inni, Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?, „World Journal of Gastroenterology”, 14 (18), 2008, s. 2838–2843, DOI: 10.3748/wjg.14.2838, PMID: 18473407, PMCID: PMC2710724 [dostęp 2021-03-09].
R.R.VicenteR.R. i inni, Erradicación de Helicobacter pylori en pacientes con úlcera péptica tras fracaso de dos tratamientos previos: estudio prospectivo guiado por cultivo, „Gastroenterologia y Hepatologia”, 25 (7), 2002, s. 438–442, DOI: 10.1016/s0210-5705(02)70283-5, PMID: 12139836 [dostęp 2021-03-09](hiszp.).
David Y.D.Y.GrahamDavid Y.D.Y., AkikoA.ShiotaniAkikoA., New concepts of resistance in the treatment of Helicobacter pylori infections, „Nature Clinical Practice. Gastroenterology & Hepatology”, 5 (6), 2008, s. 321–331, DOI: 10.1038/ncpgasthep1138, PMID: 18446147, PMCID: PMC2841357 [dostęp 2021-03-09].
DinoD.VairaDinoD. i inni, Terapia dell'infezione da Helicobacter pylori. Attuali criteri, „Recenti Progressi in Medicina”, 98 (11), 2007, s. 574–582, DOI: 10.1701/303.3583, PMID: 18044409 [dostęp 2021-03-09](wł.).
BarryB.MarshallBarryB., Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients, „Annals of Internal Medicine”, 148 (12), 2008, s. 962–963, DOI: 10.7326/0003-4819-148-12-200806170-00227, PMID: 18490666 [dostęp 2021-03-09].
YektaY.TüzünYektaY. i inni, The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia, „Hepato-Gastroenterology”, 55 (81), 2008, s. 289–293, PMID: 18507127 [dostęp 2021-03-09].
F.F.PernaF.F. i inni, Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance, „Digestive and Liver Disease”, 39 (11), 2007, s. 1001–1005, DOI: 10.1016/j.dld.2007.06.016, PMID: 17889627 [dostęp 2021-03-09].
P.I.P.I.HsuP.I.P.I. i inni, Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures, „European Journal of Clinical Investigation”, 38 (6), 2008, s. 404–409, DOI: 10.1111/j.1365-2362.2008.01951.x, PMID: 18435764 [dostęp 2021-03-09].
IntetsuI.KobayashiIntetsuI. i inni, Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005, „Journal of Clinical Microbiology”, 45 (12), 2007, s. 4006–4010, DOI: 10.1128/JCM.00740-07, PMID: 17942652, PMCID: PMC2168569 [dostęp 2021-03-09].
Mark V.M.V.GalanMark V.M.V., Arfana A.A.A.KishanArfana A.A.A., Ann L.A.L.SilvermanAnn L.A.L., Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report, „Digestive Diseases and Sciences”, 49 (7-8), 2004, s. 1088–1090, DOI: 10.1023/b:ddas.0000037792.04787.8a, PMID: 15387326 [dostęp 2021-03-09].
SotiriosS.ParaschosSotiriosS. i inni, In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori, „Antimicrobial Agents and Chemotherapy”, 51 (2), 2007, s. 551–559, DOI: 10.1128/AAC.00642-06, PMID: 17116667, PMCID: PMC1797732 [dostęp 2021-03-09].
James R.J.R.BebbJames R.J.R. i inni, Mastic gum has no effect on Helicobacter pylori load in vivo, „The Journal of Antimicrobial Chemotherapy”, 52 (3), 2003, s. 522–523, DOI: 10.1093/jac/dkg366, PMID: 12888582 [dostęp 2021-03-09].
Michael F.M.F.LoughlinMichael F.M.F., Dlawer A.D.A.Ala'AldeenDlawer A.D.A., Peter J.P.J.JenksPeter J.P.J., Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice, „The Journal of Antimicrobial Chemotherapy”, 51 (2), 2003, s. 367–371, DOI: 10.1093/jac/dkg057, PMID: 12562704 [dostęp 2021-03-09].
J.F.J.F.TombJ.F.J.F. i inni, The complete genome sequence of the gastric pathogen Helicobacter pylori, „Nature”, 388 (6642), 1997, s. 539–547, DOI: 10.1038/41483, PMID: 9252185 [dostęp 2021-03-09].
David N.D.N.BaldwinDavid N.D.N. i inni, Identification of Helicobacter pylori genes that contribute to stomach colonization, „Infection and Immunity”, 75 (2), 2007, s. 1005–1016, DOI: 10.1128/IAI.01176-06, PMID: 17101654, PMCID: PMC1828534 [dostęp 2021-03-09].
Helicobacter pylori, [w:] Bacterial Infections [online], WHO, 24 marca 2006 [zarchiwizowane z adresu 2006-03-24].
worldcat.org
Maria LucynaM.L.ZarembaMaria LucynaM.L., JerzyJ.BorowskiJerzyJ., Mikrobiologia lekarska. Podręcznik dla studentów medycyny, wyd. 3, Warszawa: Wydawnictwo Lekarskie PZWL, 2004, s. 234–239, ISBN 83-200-2896-5, OCLC749533192.